Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals

Journal of Alzheimer's Disease : JAD
R MilneC Brayne

Abstract

In clinical trials which target pathophysiological mechanisms associated with Alzheimer's disease, research participants who are recruited based on biomarker test results should be informed about their increased risk of developing Alzheimer's dementia. This paper presents the results of a qualitative focus group study of attitudes and concerns toward learning information about biomarker-based risk status among healthy research participants in the United Kingdom and Spain and people with dementia and their supporters/caregivers from countries represented in the European Working Group of People with Dementia of Alzheimer Europe. The study identified expectations related to learning risk status and preferences related to the content, quality, and follow-up of the disclosure process. The latter emphasize distinctions between risk and diagnoses, the importance of clear information about risk, and suggestions for risk reduction, as well as expectations for follow up and support. The implications of these preferences for practice are discussed. Providing details of research participants' experience and views may serve as a guide for the development of processes for the responsible disclosure of Alzheimer's disease biomarkers.

References

Jan 5, 2000·BMJ : British Medical Journal·N Mays, C Pope
Jul 27, 2006·European Journal of Human Genetics : EJHG·Bartha Maria KnoppersFrancine Durocher
Jan 12, 2008·BMJ : British Medical Journal·Jing XieUNKNOWN Medical Research Council Cognitive Function and Ageing Study collaborators
Jan 22, 2008·Patient Education and Counseling·A EdwardsH Thornton
Mar 5, 2008·Alzheimer Disease and Associated Disorders·Serena ChaoRobert C Green
May 29, 2009·The New England Journal of Medicine·George M SavvaUNKNOWN Medical Research Council Cognitive Function and Ageing Study
Jun 16, 2009·The Milbank Quarterly·Robert A Aronowitz
Jul 17, 2009·The New England Journal of Medicine·Robert C GreenUNKNOWN REVEAL Study Group
May 26, 2010·Nature Reviews. Neurology·Blossom C M StephanCarole Dufouil
Jun 24, 2010·Social Science & Medicine·Gillian ChilibeckMegha Sehdev
Oct 1, 2010·Clinical Genetics·P J MorrisonA Bradley
May 18, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Jill S GoldmanUNKNOWN American College of Medical Genetics and the National Society of Genetic Counselors
Aug 30, 2011·Journal of Medical Ethics·Lara K Kutschenko
Nov 10, 2011·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Paul K J HanNeeraj K Arora
Nov 17, 2011·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Emmanuelle LévesqueJacques Simard
Aug 25, 2012·Biomarkers in Medicine·Pieter Jelle VisserHermann-Josef Gertz
Jan 31, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Keith A JohnsonUNKNOWN Amyloid Imaging Taskforce
Feb 16, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Maria C CarrilloReisa A Sperling
Apr 16, 2013·Progress in Neurobiology·J Scott Roberts, Wendy R Uhlmann
Aug 21, 2013·International Journal of Clinical Practice·C FoxC Brayne
Sep 6, 2013·Annual Review of Genomics and Human Genetics·Denise M LautenbachRobert C Green
Sep 10, 2013·Alzheimer's Research & Therapy·Elizabeth M WiklerJohn M Benson
Mar 19, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·J Scott RobertsCathleen M Connell
Mar 22, 2014·Science Translational Medicine·Reisa A SperlingPaul Aisen
Aug 31, 2014·Mayo Clinic Proceedings·Richard J CaselliJason S Robert
Jan 1, 2013·Neurodegenerative Disease Management·J Scott RobertsGil D Rabinovici
Dec 20, 2015·The Lancet. Psychiatry·Craig W RitchieUNKNOWN European Prevention of Alzheimer's Dementia (EPAD) Consortium
Jan 12, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Yen Ying LimPeter J Snyder
Mar 19, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·José L MolinuevoJason Karlawish
Mar 29, 2016·Alzheimer's & Dementia : Translational Research & Clinical Interventions·B R OttP J Snyder
Apr 12, 2016·Journal of Alzheimer's Disease : JAD·Jennifer H LinglerRichard Schulz
Apr 23, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Gil D RabinoviciMaria C Carrillo
May 31, 2016·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Michael M WittePaula T Trzepacz

❮ Previous
Next ❯

Citations

Aug 30, 2018·Journal of Medical Ethics·Eline M BunnikMaartje H N Schermer
Nov 5, 2019·The Gerontologist·Barbara Bodorkos FriedmanIsabelle Budin-Ljøsne
Feb 27, 2018·Journal of Alzheimer's Disease : JAD·Shana D Stites
Jan 11, 2020·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Carolyn M LangloisJessica B Langbaum
Nov 27, 2019·Current Opinion in Psychiatry·Miguel E RenteríaAmaranta Manrique de Lara
May 7, 2019·Alzheimer Disease and Associated Disorders·Melissa J ArmstrongC D Mullins
Aug 29, 2020·Der Nervenarzt·Silke SchicktanzScott Stock Gissendanner
Sep 15, 2020·Frontiers in Public Health·Isabelle Budin-LjøsneLarysa Zasiekina
Mar 6, 2021·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Claire M EricksonLindsay R Clark
Jul 23, 2021·Journal of Medical Ethics·Zümrüt Alpinar-SencanPerla Werner
Sep 27, 2021·Sociology of Health & Illness·Natassia Brenman, Richard Milne
Dec 20, 2018·Lancet Neurology·Carol Brayne

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02008357
NCT02000583

Software Mentioned

REVEAL

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

BMJ : British Medical Journal
Michael Powers
The American Journal of Bioethics : AJOB
Alessandro BlasimmeEffy Vayena
© 2022 Meta ULC. All rights reserved